Prudential Financial Inc Sangamo Therapeutics, Inc Transaction History

Prudential Financial Inc

$70 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$0.42 - $1.38 $1,554 - $5,106	3,700 Added 4.09%	94,236 $63,000
Q4 2023 Feb 13, 2024	SELL	$0.3 - $0.63 $54,000 - $113,400	-180,000 Reduced 66.53%	90,536 $48,000
Q3 2023 Nov 13, 2023	SELL	$0.58 - $1.47 $67,512 - $171,108	-116,400 Reduced 30.08%	270,536 $162,000
Q2 2023 Aug 11, 2023	BUY	$1.11 - $1.74 $248,029 - $388,803	223,450 Added 136.68%	386,936 $503,000
Q1 2023 May 12, 2023	BUY	$1.66 - $3.67 $271,386 - $599,993	163,486 New	163,486 $287,000
Q4 2021 Feb 14, 2022	SELL	$7.29 - $10.97 $105,413 - $158,626	-14,460 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.01 - $12.01 $29,904 - $39,861	3,319 Added 29.79%	14,460 $130,000
Q2 2021 Aug 16, 2021	BUY	$10.17 - $12.64 $113,303 - $140,822	11,141 New	11,141 $133,000
Q1 2021 May 12, 2021	SELL	$10.88 - $17.05 $114,686 - $179,724	-10,541 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$9.23 - $18.18 $6,045 - $11,907	-655 Reduced 5.85%	10,541 $164,000
Q3 2020 Nov 16, 2020	SELL	$9.38 - $12.48 $3,198 - $4,255	-341 Reduced 2.96%	11,196 $106,000
Q2 2020 Aug 12, 2020	BUY	$6.21 - $11.83 $1,925 - $3,667	310 Added 2.76%	11,537 $103,000
Q1 2020 May 12, 2020	SELL	$5.05 - $8.85 $4,777 - $8,372	-946 Reduced 7.77%	11,227 $71,000
Q4 2019 Feb 11, 2020	BUY	$8.03 - $11.7 $1,622 - $2,363	202 Added 1.69%	12,173 $101,000
Q3 2019 Nov 13, 2019	SELL	$9.05 - $12.22 $17,258 - $23,303	-1,907 Reduced 13.74%	11,971 $108,000
Q2 2019 Aug 08, 2019	BUY	$8.75 - $13.03 $11,112 - $16,548	1,270 Added 10.07%	13,878 $0
Q1 2019 May 15, 2019	BUY	$7.72 - $12.81 $15,301 - $25,389	1,982 Added 18.65%	12,608 $0
Q4 2018 Feb 07, 2019	SELL	$9.51 - $16.6 $1,141 - $1,992	-120 Reduced 1.12%	10,626 $121,000
Q3 2018 Nov 07, 2018	BUY	$13.05 - $19.05 $1,305 - $1,905	100 Added 0.94%	10,746 $0
Q2 2018 Aug 13, 2018	SELL	$13.9 - $19.8 $6.88 Million - $9.8 Million	-494,890 Reduced 97.89%	10,646 $0
Q1 2018 May 04, 2018	BUY	$16.7 - $26.35 $6.49 Million - $10.2 Million	388,480 Added 331.88%	505,536 $0
Q4 2017 Feb 13, 2018	BUY	$11.6 - $17.35 $1.36 Million - $2.03 Million	117,056	117,056 $1.92 Million

Others Institutions Holding SGMO

# of Institutions

111

Shares Held

56.4M

Call Options Held

576K

Put Options Held

1.17M

Wasatch Advisors Inc Salt Lake City, UT

19.4M
Shares

$22.4 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

9.6M
Shares

$11 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.85M
Shares

$5.58 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.7M
Shares

$5.41 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.35M
Shares

$2.71 Million
0.0% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $180M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account